pH-responsive shielding of non-viral gene vectors
- 1 September 2006
- journal article
- review article
- Published by Informa Healthcare in Expert Opinion on Drug Delivery
- Vol. 3 (5) , 563-571
- https://doi.org/10.1517/17425247.3.5.563
Abstract
PEG shielding of non-viral vectors reduces undesired interactions with the extracellular environment. Combination with cell-binding domains enables in vivo targeting via specific attachment to the target cells. Pegylation, however, also interferes with effective intracellular nucleic acid delivery. Consistently triggered removal of the PEG shield after reaching the target cell would make non-viral vectors more compatible with the intracellular delivery steps. Physiological triggers may include changes in pH, enzyme concentration or redox potential. This review focuses on pH-sensitive shielding strategies that exploit the endosomal acidification process after endocytosis for deshielding of the delivery system.Keywords
This publication has 54 references indexed in Scilit:
- Tumor-targeted gene therapy: strategies for the preparation of ligand–polyethylene glycol–polyethylenimine/DNA complexesJournal of Controlled Release, 2003
- Nonviral gene delivery to the lung with copolymer-protected and transferrin-modified polyethylenimineBiochimica et Biophysica Acta (BBA) - General Subjects, 2002
- Importance of Lateral and Steric Stabilization of Polyelectrolyte Gene Delivery Vectors for Extended Systemic CirculationMolecular Therapy, 2002
- The Structure of PEG-Modified Poly(Ethylene Imines) Influences Biodistribution and Pharmacokinetics of Their Complexes with NF-κB Decoy in MicePharmaceutical Research, 2002
- Stabilized plasmid-lipid particles for systemic gene therapyGene Therapy, 2000
- Receptor-targeted gene delivery viafolate-conjugated polyethylenimineAAPS PharmSci, 1999
- Transfection and physical properties of various saccharide, poly(ethylene glycol), and antibody-derivatized polyethylenimines (PEI)The Journal of Gene Medicine, 1999
- PEGylated DNA/transferrin–PEI complexes: reduced interaction with blood components, extended circulation in blood and potential for systemic gene deliveryGene Therapy, 1999
- Stabilization of poly-l-lysine/DNA polyplexes for in vivo gene delivery to the liverBiochimica et Biophysica Acta (BBA) - Gene Structure and Expression, 1999
- Polyethylene glycol-grafted poly-l-lysine as polymeric gene carrierJournal of Controlled Release, 1998